GlassScriptPhysician profile
Ryan Michael Finn
NPI 1558898684
$5,248.23
in general payments reported to CMS, 2019-2025
7 companies · $2,054 in 2025
The $2,054 reported for 2025 was more than what 83% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.29 · 2021: $1,387 · 2022: $1,342 · 2023: $233 · 2024: $142 · 2025: $2,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,555 · Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,554.82 |
| Food and Beverage | $874.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,595.27 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,430.20 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,194.43 | 2022-2023 | Intellis Adaptivestim |
| Si-Bone, INC. | $841.79 | 2025 | |
| Nevro Corp. | $140.09 | 2019-2023 | Senza |
| Stryker Corporation | $26.18 | 2025 | Optablate, Spinejack |
| Vertos Medical, INC. | $20.27 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Finn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.